CENTOGENE is a rare disease company dedicated to transforming genetic, clinical and biochemical data into medical solutions for patients and their families. We are focused on creating genetic knowledge to support informed treatment decisions and accelerating the development of new orphan drugs.
At the core of our activities are the unique data repository and biobank which include epidemiologic, phenotypic, biochemical and genetic information, as well as biomaterial for over 400,000 patients from more than 120 countries, reflecting the genetic differences among global ethnicities.
We believe that it is the only platform that comprehensively analyzes multilevel data to improve the understanding of rare diseases, which can help in the accurate and timely diagnosis of patients. Our suite of solutions, which also include the development of innovative biomarkers, can provide significant support to the efforts of our pharmaceutical partners to bring more Orphan Drugs to the market faster.